Trials / Recruiting
RecruitingNCT07270016
Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes: Pilot Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 16 Years – 24 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18. Participants will be asked to fill out surveys about diabetes, physical activity, and diet before and after wearing a CGM for 30 days. At the end of wearing the CGM, participants will complete an interview about their experience.
Conditions
- Diabetes Mellitus, Type 2
- Hyperglycemia
- Physical Inactivity
- Lifestyle (Sedentary Behavior and Physical Activity)
- Continuous Glucose Monitoring
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Healthmine app | Participants will wear study-provided continuous glucose monitoring device and Fitbit physical activity tracker for 30 consecutive days. During the same period, they will use an investigator-developed smartphone app (Healthmine), which is being developed to pair CGM and Fitbit data. Participants will receive up to one message about health behavior change (e.g., physical activity, nutrition) daily and will be able to use Healthmine to log exercise and dietary intake. |
Timeline
- Start date
- 2026-02-16
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2025-12-08
- Last updated
- 2026-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07270016. Inclusion in this directory is not an endorsement.